Transarterial Chemoembolization (TACE) for Malignant Hepatic Tumors in Children

  • Nghia-Jack Vo
  • Fredric A. Hoffer
  • Sandeep S. Vaidya


Primary malignant liver cancers in children have an overall incidence of two cases per million. Hepatoblastoma (HB) is the most common, and the majority will present in infants and toddlers within the first 2 years of life. On the other hand, hepatocellular carcinoma (HCC) which is the second most frequent malignant liver tumor will present later, typically in school-aged children or adolescents. The fundamental principle for treatment is complete surgical resection of the tumor. Unfortunately 50 % of children with HB and 70 % of those with HCC present initially as inoperable due to the extent of tumor involvement, vascular invasion, or distant metastasis. The prognosis for children that cannot ultimately achieve a complete tumor resection or transplant is dismal. HB is generally chemosensitive, particularly to platinum-based agents such as cisplatin. Following systemic chemotherapy up to 85 % are appropriate candidates for surgical resection. However, HCC remains relatively chemoresistant, and the fibrolamellar type of HCC most often attributable to children (13–22 % of HCC in children) does not respond any differently than the typical HCC with current therapeutic regimens, having an overall survival rate below 25 % at 3 years.


Superior Mesenteric Artery Tumor Lysis Syndrome Hepatic Abscess Complete Tumor Resection Normal Liver Parenchyma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Pham TH, Iqbal CW, Grams JM, et al. Outcomes of primary liver cancer in children: an appraisal of experience. J Pediatr Surg. 2007;42:834–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Meyers RL. Tumors of the liver in children. Surg Oncol. 2007;16:195–203.PubMedCrossRefGoogle Scholar
  3. 3.
    Malogolowkin MH, Stanley P, Steele DA, et al. Feasibility and toxicity of chemoembolizations for children with liver tumors. J Clin Oncol. 2000; 18(6):1279–84.PubMedGoogle Scholar
  4. 4.
    Tannuri ACA, Tannuri U, Givelli NEM, et al. Surgical treatment of hepatic tumors in children: lessons learned from liver transplantation. J Pediatr Surg. 2009; 44:2083–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Cruz O, Laguna A, Vancells M, et al. Fibrolamellar hepatocellular carcinoma in an infant and literature review. J Pediatr Hematol Oncol. 2008;30(12):968–71.PubMedCrossRefGoogle Scholar
  6. 6.
    Xuewu J, Jianhong L, Xianliang H, et al. Combined treatment of hepatoblastoma with transcatheter arterial chemoembolizations and surgery. J Pediatr Hematol Oncol. 2006;23:1–9.CrossRefGoogle Scholar
  7. 7.
    Chou FI, Fang KC, Chung C, et al. Lipiodol uptake and retention by human hepatoma cells. Nucl Med Biol. 1995;22(3):379–86.PubMedCrossRefGoogle Scholar
  8. 8.
    Vogl TJ, Scheller A, Jakob U, et al. Transarterial chemoembolizations in the treatment of hepatoblastoma in children. Eur Radiol. 2006;16:1393–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Ohtsuka Y, Matsunaga T, Yoshida H, et al. Optimal strategy of preoperative transcatheter arterial chemoembolizations for hepatoblastoma. Surg Today. 2004;34:127–33.PubMedCrossRefGoogle Scholar
  10. 10.
    Nakamura H, Hashimoto T, Oi H, et al. Transcatheter oily chemoembolizations of hepatocellular carcinoma. Radiology. 1989;170:783–6.PubMedGoogle Scholar
  11. 11.
    Tashjian DB, Moriarty KP, Courtney RA, et al. Preoperative chemoembolization for unresectable hepatoblastoma. Pediatr Surg Int. 2002;18:187–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Li J, Chu J, Yang J, et al. Preoperative transcatheter selective arterial chemoembolizations in treatment of unresectable hepatoblastoma in infants and children. Cardiovasc Intervent Radiol. 2008;31:1117–23.PubMedCrossRefGoogle Scholar
  13. 13.
    Czuaderna P, Abrzezniak G, Narozanski W, et al. Preliminary experience with arterial chemoembolizations for hepatoblastoma and hepatocellular carcinoma in children. Pediatr Blood Cancer. 2006; 46:825–8.CrossRefGoogle Scholar
  14. 14.
    Avila LF, Luis AL, Hernandez F, et al. Liver transplantation for malignant tumours in children. Eur J Pediatr Surg. 2006;16:411–4.PubMedCrossRefGoogle Scholar
  15. 15.
    Ismail H, Broniszczak D, Kalicinski P, et al. Liver transplantation in children with hepatocellular carcinoma Do Milan Criteria apply to pediatric patients? Pediatr Transplant. 2008;13(6):682–92.CrossRefGoogle Scholar
  16. 16.
    Llovet JM, Real MI, Montana X, et al. Arterial embolization or chemoembolizations versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trail. Lancet. 2002;359:1734–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Lo CM, Nhan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolizations for unresectable hepatocellular carcinoma. Hepatology. 2002;35(5):1164–71.PubMedCrossRefGoogle Scholar
  18. 18.
    Chung JW, Park JH, Han JK, et al. Hepatic tumors: predisposing factors for complications of transcatheter oily embolization. Radiology. 1996;198:33–40.PubMedGoogle Scholar
  19. 19.
    Heran MKS, Marshalleck F, Temple M, et al. Joint quality improvement guidelines for pediatric arterial access and arteriography: from the Society of Interventional Radiology and Pediatric Radiology. Pediatr Radiol. 2010;40:237–50.PubMedCrossRefGoogle Scholar
  20. 20.
    Bissler JJ, Racadio J, Donnelly LF, et al. Reduction of postembolization syndrome after ablation of renal angiomyolipomas. Am J Kidney Dis. 2002; 39:966–71.PubMedCrossRefGoogle Scholar
  21. 21.
    Arcement CM, Towbin RB, Meza MP, et al. Intrahepatic chemoembolizations in unresectable pediatric liver malignancies. Pediatr Radiol. 2000; 30:779–85.PubMedCrossRefGoogle Scholar
  22. 22.
    Li CP, Chao Y, Chen LT, et al. Fever after transcatheter arterial chemoembolizations for hepatocellular carcinoma: incidence and risk factor analysis. Scand J Gastroenterol. 2008;43:992–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Yamaura K, Higashi M, Akiyoshi K, et al. Pulmonary lipiodol embolism during transcatheter arterial chemoembolizations for hepatoblastoma under general anesthesia. Eur J Anaesthesiol. 2000;17(11):704–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Moghissi ES, Korytkowski MT, DiNardo M, et al. American association of clinical endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119–31.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Nghia-Jack Vo
    • 1
  • Fredric A. Hoffer
    • 2
  • Sandeep S. Vaidya
    • 3
  1. 1.Department of Radiology, Pediatric Imaging and Interventional RadiologyChildren’s Hospital of Wisconsin, Medical College of WisconsinMilwaukeeUSA
  2. 2.Department of RadiologyUniversity of WashingtonSeattleUSA
  3. 3.Department of Radiology, Vascular and Interventional RadiologySeattle Children’s Hospital and the University of WashingtonSeattleUSA

Personalised recommendations